Drug Target Review – Issue #1 2017
Posted: 9 March 2017 | Drug Target Review | No comments yet
Included in this issue: Importance of building patient trust; Vaccines & Immunology; Oncology; Assays; Biomarkers; and Antibodies…
- Foreword: The importance of building patient trust
Pamela Brankin, Head of Marketing and Communications, Aridhia - In-Depth Focus: Assays
- Vaccines & Immunology: Bispecific antibodies Q&A
Lou Matis, Chief Development Officer at Pieris - In-Depth Focus: Antibodies
- Oncology: Targeting GAS6 in cancer, fibrosis and viral infection
Rebecca Miao and Amato J. Giaccia, Stanford University, and Raymond Tabibiazar, Aravive Biologics - Oncology: Nanoparticle-mediated enzyme delivery for application in cancer therapy
Negin Mokhtari, Mukanth Vaidyanathan, Ya-San Yeh, and Sadik Esener, University of California, San Diego
- In-Depth Focus: Biomarkers
The digital version of Issue #1 2017 is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related topics
Antibodies, Assays, Biomarkers, Immunology, Oncology, Vaccine
